GSK983: A novel compound with broad-spectrum antiviral activity

Antiviral Research

Volumn 82, Issue 1, 2009, Pages 1-11

  Harvey, Robert ^a   Brown, Kevin ^a   Zhang, Qin ^a   Gartland, Margaret ^a   Walton, Leslie ^a   Talarico, Christine ^a   Lawrence, Wendell ^a   Selleseth, Dean ^a   Coffield, Neil ^a   Leary, Jeffry ^a   Moniri, Kelly ^a   Singer, Sara ^a   Strum, Jay ^a   Gudmundsson, Kristjan ^a   Biron, Karen ^a   Romines, Karen R ^a   Sethna, Phiroze ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

GSK983; Interferon stimulated genes; Novel antiviral; Tetrahydrocarbazole

Indexed keywords

(6 CHLORO 2,3,4,9 TETRAHYDRO 1H CARBAZOL 1 YL) 2 PYRIDINECARBOXAMIDE; ALPHA INTERFERON; ANTIVIRUS AGENT; CELL PROTEIN; GSK 983; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS 5; ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL DEGENERATION; CELL GROWTH; CELL IMMORTALIZATION; CELL LINE; CELL MATURATION; CELL MEMBRANE PERMEABILITY; CELL MOTION; CELL STRAIN HEK293; CELL STRAIN U937; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSTASIS; DRUG MECHANISM; DRUG TARGETING; EMBRYO; ENDOTHELIUM CELL; EPISOME; EPSTEIN BARR VIRUS; FIBROBLAST; GROWTH INHIBITION; HELA CELL; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; KERATINOCYTE; LEUKEMIA CELL LINE; LYMPHOCYTE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; SIMIAN VIRUS 40; STEM CELL; VERO CELL; VIROGENESIS; VIRUS INHIBITION; VIRUS REPLICATION; WART VIRUS;

ANTIVIRAL AGENTS; APOPTOSIS; CARBAZOLES; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; DNA VIRUSES; HUMANS; VIRUS REPLICATION;

ADENOVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; PAPILLOMAVIRIDAE; POLYOMAVIRUS; SIMPLEXVIRUS;

EID: 62049083306     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2008.12.015     Document Type: Article

References (23)

1. Barltrop J.A., Owen T.C., Cory A.H., and Cory J.G. 5-(3-Carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans as cell-viability indicators. Bioorg. Med. Chem. Lett. 1 (1991) 611-614
2. Boggs S.D., Cobb J.D., Gudmundsson K.S., Jones L.A., Matsuoka R.T., Millar A., Patterson D.E., Samano V., Trone M.D., Xie S., and Zhou X. Efficient asymmetric synthesis of N-[(1R)-6-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl]-2-pyridinecarboxamide for treatment of human papillomavirus infections. Org. Process Res. Dev. 11 (2007) 539-545
3. Borden E.C., Sen G.C., Uze G., Silverman R.H., Ransohoff R.M., Foster G.R., and Stark G.R. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6 (2007) 975-990
4. Browne E.P., Wing B., Coleman D., and Shenk T. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J. Virol. 75 (2001) 12319-12330
5. Cory A.H., Owen T.C., Barltrop J.A., and Cory J.G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3 (1991) 207-212
6. Der S.D., Zhou A., Williams B.R., and Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15623-15628
7. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., and Markowitz L.E. Prevalence of HPV infection among females in the United States, 1947-1984. J. Am. Med. Assoc. 297 (2007) 813-819
8. Eaves C.J. Assays of hemopoietic progenitor cells. In: Beutler E., Lichtman M.A., Coller B.A., and Kipps T.J. (Eds). Williams Hematology (1995), McGraw-Hill, Inc. L22-L26
9. Ferris R.G., Hazen R.J., Roberts G.B., St. Clair M.H., Chan J.H., Romines K.R., Freeman G.A., Tidwell J.H., Schaller L.T., Cowan J.R., Short S.A., Weaver K.L., Selleseth D.W., Moniri K.R., and Boone L.R. Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitor. Antimicrob. Agents Chemother. 49 (2005) 4046-4051
10. Frisan T., Levitsky V., and Masucci M. Generation of lymphoblastoid cell lines (LCLs). In: Wilson J.B., and May G.H.W. (Eds). Epstein-Barr Virus Protocols (2001), Humana Press 123-127
11. Grunberger C., Wyles D.L., Kaihara K.A., and Schooley R.T. 3-Drug synergistic interactions of small molecular inhibitors of hepatitis C virus replication. J. Inf. Dis. 197 (2008) 42-45
12. Hill A.V. The possible effects of the aggregation of the molecules of hemoglobin on its dissociation curves. J. Physiol. (Lond.) 40 (1910) 4-8
13. Knipe D.M., and Howley P.M. Fields Virology. 5th ed. (2007), Lippincott Williams & Wilkins
14. Kudoh A., Daikoku T., Ishimi Y., Kawaguchi Y., Shirata N., Iwahori S., Isomura H., and Tsurumi T. Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein-Barr virus productive replication. J. Virol. 80 (2006) 10064-10072
15. Lee J.H., Yi S.M., Anderson M.E., Berger K.L., Welsh M.J., Klingelhutz A.J., and Ozbun M.A. Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 2094-2099
16. Leyssen P., De Clerq E., and Neyts J. Molecular strategies to inhibit the replication of RNA viruses. Antivir. Res. 78 (2008) 9-25
17. Mager M.E. Data Analysis in Biochemistry and Biophysics (1972), Academic Press, Inc.
18. Morens D.M., and Fauci A.S. Dengue and hemorrhagic fever: a potential threat to public health in the United States. J. Am. Med. Assoc. 299 (2008) 214-216
19. Radaeva S., Jaruga B., Hong F., Kim W., Fan S., Cai H., Strom S., Liu Y., El-Assal O., and Gao B. Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes. Gastroenterology 122 (2008) 1020-1034
20. Randall R.E., and Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89 (2008) 1-47
21. Schlect J., Schellhorn S., Dezube B., and Jacobson J. New approaches in the treatment of HIV/AIDS - focus on maraviroc and other CCR5 antagonists. Ther. Clin. Risk Manage. 4 (2008) 473-485
22. Song B., Liu J.J., Yeh K.C., and Knipe D.M. Herpes simplex virus infection blocks events in the G1 phase of the cell cycle. Virology 267 (2000) 326-334
23. Stanley M.A., Browne H.M., Appleby M., and Minson A.C. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int. J. Cancer 43 (1989) 672-676